Publication:
Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza a infection

dc.contributor.authorKenta Nakamuraen_US
dc.contributor.authorBrian S. Schwartzen_US
dc.contributor.authorNiklas Lindegårdhen_US
dc.contributor.authorChris Kehen_US
dc.contributor.authorB. Joseph Guglielmoen_US
dc.contributor.otherUCSF School of Medicineen_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-24T09:30:52Z
dc.date.available2018-09-24T09:30:52Z
dc.date.issued2010-04-01en_US
dc.description.abstractThe safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to the possible increased risk of complications associated with high-dose oseltamivir therapy for 2009 H1N1 influenza A infection. © 2010 by the Infectious Diseases Society of America. All rights reserved.en_US
dc.identifier.citationClinical Infectious Diseases. Vol.50, No.7 (2010)en_US
dc.identifier.doi10.1086/651166en_US
dc.identifier.issn10584838en_US
dc.identifier.other2-s2.0-77749326569en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/29721
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77749326569&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePossible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza a infectionen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77749326569&origin=inwarden_US

Files

Collections